onbudget

See Every Budget Together

Saved

Text and display settings

Your choices are saved in this browser and apply across onbudget.

Text and display size
Display mode
Institution
대구광역시 달서구
Department
보건행정과

○결핵진단검사비 경정 29,593,000원

Programme 보건소 결핵관리사업(결핵진단검사비)

Amounts and period

Budgeted amount
29,593,000 KRW
기정액
18,971,000 KRW
Change
+10,622,000 KRW +56.0%

Programme hierarchy and share

The selected item’s share of each parent budget, calculated from amounts in the same source document.

A share is not calculated for missing or partial amounts, non-positive parent amounts, or an item amount greater than its parent.

  1. Department 보건행정과 13,770,521,000 KRW
  2. Policy 주민의 평생건강을 위한 신뢰받는 보건의료서비스 제공(보건행정과) 8,331,449,000 KRW
  3. Programme 지역주민 건강관리 4,075,526,000 KRW
  4. Project 보건소 결핵관리사업(결핵진단검사비) 29,593,000 KRW
  5. Budget category 민간이전 29,593,000 KRW
  6. Statistical item 의료 및 회복비 29,593,000 KRW
  7. Item ○결핵진단검사비 경정 29,593,000원 29,593,000 KRW
Category–statistical code
307-01
Group
Not provided in source

Original description

Not provided in source

Institution and programme names are shown as the original Korean source text.

Detailed budget items

1 items
  1. ○결핵진단검사비 경정 29,593,000원 307-01 Page 2 Selected item 29,593,000 KRW Opens in a new window

Data source

View source document details
Document ID
doc_6kyhdaf5r45zvejzv05k323b8h
Source document status
Available
File type
application/pdf
File size
313.876 KiB
Location inside the source
Page 2 Row 6 Line 2 Column level4

Source and reference

FY 2024 release No source record

Fiscal year of record
2024
Fetched from the source
2026-07-29 18:48
Read and interpreted
2026-07-29 18:48
Query snapshot refreshed
2026-09-02 03:23
Item ID
bi_2fdnq5zpdwf3jhfajbmy5ddnsg

Similar budgets

5 items
Items share the same budget classification and a related name. Different years may be included. The name search uses the keyword without a classification filter.

Keyword “결핵진단검사비” · classification 307-01

Search related names

AI analysis report

AI analysis reports are not yet available.